Sharp and large differences in prices for commercial health insurers and Medicare have led some policymakers to propose a larger public role in determining provider prices in commercial coverage.
Other featured articles
Federal Policy Options to Realize the Potential of All Payer Claims Databases
An all-payer claims database (APCD) is a system that collects health care claims and related data from all (or nearly all) entities that pay for health care services in a geographic area, including private and public health plans.
Georgia’s Latest 1332 Proposal Continues To Violate the ACA
Scholars from the USC-Brookings Schaeffer Initiative for Health Policy Georgia’s latest 1332 Proposal, analyzing its major analytical errors and procedural deficiencies that render it unapprovable.
Prospects for Future Advances in Alzheimer’s Disease
This paper revisits expert predictions for future advances in Alzheimer’s disease (AD) made in 2001 and projects future breakthroughs over the next 20 years.
Key Barriers for Clinical Trials for Alzheimer’s Disease
Alzheimer’s disease (AD) clinical trials are more complicated, costly, and slower than trials for other diseases. Addressing barriers would accelerate the approval of innovative therapies.